Sector Vertex Pharmaceuticals Incorporated

Aandelen

VRTX

US92532F1003

Farmaceutische producten

Beurs gesloten - 22:00:00 20-11-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
515,02 USD -1,08% Intraday-grafiek van Vertex Pharmaceuticals Incorporated -4,38% +13,60%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-1,08%-4,38%+0,07%-4,67%+13,60%+21,95%+44,33%+181,62%+475,83% 131 mld.
-0,30%-6,68%+4,94%+8,25%+25,35%+29,12%+125,42%+416,73%+1.657,02% 1.200 mld.
+1,25%-5,35%+4,28%+1,16%+30,69%+33,19%+80,42%+66,04%+134,46% 651 mld.
+0,94%-2,99%-1,00%+9,31%+25,26%+24,73%+106,93%+146,21%+372,90% 506 mld.
-0,60%-1,95%+1,77%+6,72%+20,90%+27,26%+67,32%+7,26%+71,03% 377 mld.
+0,69%-9,50%-9,83%-10,25%+27,04%+40,80%+30,23%+65,70%+116,13% 330 mld.
+0,41%-4,70%+1,00%+1,12%+16,57%+27,23%+51,59%+68,02%+78,44% 288 mld.
+0,81%-4,08%+6,29%+10,95%-2,74%-1,74%+32,71%+58,18%+210,21% 272 mld.
-0,15%-6,45%-0,75%+0,44%+33,10%+29,63%+64,18%+111,39%+199,97% 236 mld.
-0,06%-0,98%+6,34%+16,03%+35,60%+33,15%+118,99%+142,29%+123,04% 206 mld.
-0,25%-5,01%+1,26%-10,69%-18,68%-15,80%-62,38%-29,59%+130,80% 171 mld.
-0,51%-5,16%-9,00%-1,40%+10,04%+12,30%-8,61%-46,06%-12,96% 156 mld.
+0,68%-3,03%+3,82%+27,50%+30,37%+25,90%+136,09%+384,12%+663,61% 123 mld.
+0,79%-7,30%-4,67%-10,19%+9,01%+27,99%+20,25%+1,68%+3,59% 120 mld.
+1,35%-3,06%+15,41%+9,17%+2,66%-0,47%-0,59%-4,48%+11,66% 112 mld.
+0,85%-3,61%-1,39%-4,06%+0,99%+4,66%+30,86%-3,13%-3,19% 96,76 mld.
-0,19%-3,64%+14,02%+11,38%+19,28%+24,92%+14,85%+41,06%+131,63% 92,39 mld.
-2,17%-12,70%-19,45%+46,26%+561,24%+772,09%+146,96%-26,07% - 78,9 mld.
-2,16%-1,00%+10,56%+0,11%-13,76%-14,12%+45,68%+72,88%+548,24% 73,69 mld.
-1,31%-2,11%+0,03%+6,08%+19,45%+32,41%-9,07%-33,73%+54,01% 69,91 mld.
Gemiddelde -0,03%-4,66%+1,19%+5,66%+42,30%+56,76%+51,81%+81,01%+261,39% 265 mld.
Gewogen gemiddelde per kap. +0,25%-5,05%+1,82%+5,01%+28,52%+35,43%+73,21%+150,34%+518,79%
  1. Beurs
  2. Aandelen
  3. Koers VRTX
  4. Sector Vertex Pharmaceuticals Incorporated